SGMT
Sagimet Biosciences Inc. Series A
9.20$
+1.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -29.3% | -42.1% | +90.9% | +6.7% | -0.8% | -4.0% | +8.6% | +5.6% | +0.2% | +8.8% | +100.7% | – | |
| – | -147.7% | – | – | -113.9% | – | -119.8% | – | – | -712.4% | – | -66.8% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -2,605.2% | – | +1,478.5% | -65.4% | -489.4% | – | +19,044.0% | -28.8% | -335.1% | – | |
| – | -96.0% | +2,880.3% | -100.0% | -100.0% | – | – | – | +27,300.0% | -100.0% | – | – | – | |
| – | -132.0% | – | -179.5% | – | – | – | – | – | – | -36.4% | +18,882.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.